Impact of GLP-1 Receptor Agonists on Patients With IPMN

Clinical trial NCT07014709 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07014709
Sponsor: Hôpital Fribourgeois
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

IPMN IPMN, Pancreatic GLP-1 Intraductal Papillary Mucinous Neoplasm of Pancreas Glucagon-Like Peptide-1 Receptor Agonists

Start date: 2025-05-31
Primary completion: 2026-10-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.